Address
Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States
Phone
Website
Recent investment activity
KANDO id: 30232
Corporate information
Registration country
Funding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 104Company | Profile | Country | Funding | ||
---|---|---|---|---|---|
Inhibitex Inc | N/A | ||||
Horizon Therapeutics Inc | Biopharmaceutical company focused on the rapid development and commercialization of therapeutic treatments for mild-to-moderate pain management. | N/A | |||
Salix Pharmaceuticals Inc | US specialty pharmaceutical company | N/A | |||
Cell Biosciences Inc | N/A | ||||
Novacept Inc | Commercializing innovative medical devices to improve the quality and cost-effectiveness of healthcare for women. | N/A | |||
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | |||
Prism Pharmaceuticals Inc | Develops and commercializes branded cardiovascular injectable products | N/A | |||
BreatheAmerica Inc | N/A | ||||
Arsenal Medical Inc | Biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. | N/A | |||
LifeCell | Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues. | N/A | |||
LipoSonix Inc | A medical device company focused on the development of proprietary technology for noninvasive cosmetic surgery applications. | N/A | |||
Chroma Therapeutics Ltd | Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance | N/A | |||
Orthovita Inc | Orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies | N/A | |||
PAREXEL | PAREXEL is a public Core Company formed as a global, full service Contract Research Organization (CRO). | N/A | |||
Corium International Inc | N/A | ||||
Healthcare Brands Intl Ltd | Committed to translating innovative science into meaningful consumer brands. Sold subsidiary, Antula Healthcare, for SEK 1.8bn in April 2011. | N/A | |||
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | N/A | |||
Abiomed | Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump with integrated motors and sensors. | N/A | |||
Endologix Inc | Develops and manufactures minimally invasive treatments for vascular diseases. | N/A | |||
Elusys Therapeutics Inc | Develops antibody-based therapies to treat infectious diseases. | N/A | |||
Echo Therapeutics | Develops needle-free, wireless, transdermal continuous glucose monitoring system. | N/A | |||
MicroMed Technology | Developer of miniaturized heart pump technology. | N/A | |||
Dow Pharmaceutical Sciences LLC | N/A | ||||
Curis Inc | Develops innovative therapeutics targeting cancer network disruption | N/A | |||
Health Grades Inc | Provides reports and ratings to guide patients to better care providers | N/A |